John Moran
Family Medicine · Davis Monthan Afb, AZNPI 1255430823
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,016 and has fallen 85.5% since, to $147 in 2021.
Across 108 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$279
- Amgen$244
- Teva Pharmaceuticals USA, Inc.$140
- Pfizer$131
- Medtronic$130
- Lilly USA, LLC$118
- plus $924 from 23 others
What the payments were for
- Food & beverage$1,965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $279 |
| Amgen | 15 | $244 |
| Teva Pharmaceuticals USA, Inc. | 8 | $140 |
| Pfizer | 10 | $131 |
| Medtronic | 9 | $130 |
| Lilly USA, LLC | 7 | $118 |
| SK Life Science, Inc. | 6 | $110 |
| UCB, Inc. | 5 | $103 |
| GSK | 7 | $98 |
| AbbVie | 6 | $93 |
| Boehringer Ingelheim | 3 | $59 |
| Sanofi | 2 | $47 |
| Novo Nordisk | 3 | $40 |
| Novartis | 2 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| GE HealthCare | 1 | $32 |
| Lundbeck LLC | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Boston Scientific | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZERBAXA$244
How this compares
$1,965 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Davis Monthan Afb
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
- Ryan CaseyYuma$231K
- Suzanne BentzMesa$174K
- Brent AllanParadise Valley$108K
- Ahmed AghaPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.